Lv1
92 积分 2024-06-17 加入
Zanamivir-Amantadine Conjugate: A Dual-Action Agent with Broad-Spectrum Synergistic Antiviral Efficacy
3天前
已完结
Respiratory syncytial virus infection and novel interventions
1个月前
已完结
Structure-Guided Design of Potent and Selective Covalent Inhibitors Targeting the SARS-CoV-2 Papain-like Protease
1个月前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
1个月前
已完结
Fragment-to-Lead Medicinal Chemistry Publications in 2024: A Tenth Annual Perspective
1个月前
已完结
Evaluation of the patent portfolio for helicase-primase inhibitor ABI-5366 of Assembly Biosciences Inc
2个月前
已完结
On the origins of SARS-CoV-2 main protease inhibitors
2个月前
已完结
Status of advanced respiratory syncytial virus antiviral therapeutics 2025
2个月前
已完结
Surface-engineering RNA nanoparticles for targeted and efficient hepatocellular carcinoma drug delivery
2个月前
已完结
皖公网安备34019202002308
